ArticleBMC cancer2025
Deep learning automatic segmentation and radiomics model for diagnosing pancreatic solid neoplasms in MRI.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundTo develop and validate a deep learning tool for the automatic segmentation of pancreatic solid neoplasms and to establish a radiomics model for diagnosing these solid neoplasms in MRI. MATERIALS AND
methodsThis retrospective study employed a three-dimensional nnU-Net-based model trained in plain MRI from patients who underwent resection for pancreatic neoplasms. A radiomics model was developed for diagnosing pancreatic neoplasms based on automatic segmentation. The segmentation performance of the deep learning model was quantitatively evaluated using dice similarity coefficient (DSC). The performance of the radiomics model was assessed through receiver operating characteristic analysis.
resultsThe study included 165 and 89 patients in the training and testing cohorts. The deep learning model achieved excellent automatic segmentation performance, with mean DSC values of 0.82 on T2WI and 0.91 on DWI in the training cohort, and 0.64 on T2WI and 0.70 on DWI in the testing cohort, respectively. For pancreatic lesions smaller than 2 cm, the DSC values were 0.74 on T2WI and 0.92 on DWI in the training cohort, and 0.51 on T2WI and 0.62 on DWI in the testing cohort. Nine radiomics signatures were selected based on ROIs obtained from the automatic segmentation. The radiomics diagnostic model exhibited favorable performance in distinguishing pancreatic ductal adenocarcinomas (PDACs) from neuroendocrine neoplasms and solid pseudopapillary neoplasms, with AUCs of 0.968 and 0.790 in the training and testing cohorts, respectively.
conclusionsThe deep learning automatic segmentation tool accurately detected pancreatic neoplasms in MRI scans, with reasonable efficiency for tumors smaller than 2 cm. The radiomics diagnostic model demonstrated favorable performance in differentiating PDACs from neuroendocrine neoplasms and solid pseudopapillary neoplasms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.